Literature DB >> 17174237

Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure.

James E Tisdale1, Steven Borzak, Hani N Sabbah, Hisashi Shimoyama, Sidney Goldstein.   

Abstract

BACKGROUND: Heart failure increases the risk of atrial fibrillation (AF), which frequently results in heart failure progression. This prospective study examined the contribution of hemodynamic and neurohormonal activation to the spontaneous occurrence of AF in heart failure, and assessed the effects of AF on left ventricular (LV) function and neurohormonal activation. METHODS AND
RESULTS: Heart failure (LV ejection fraction [LVEF] 25%-30%) was induced in 27 dogs via sequential coronary microembolizations. Hemodynamic and neurohormonal measurements were performed at 1 month (prior to development of AF) and 4 months post-embolization. During the time between measurements, 10 dogs developed spontaneous AF. Plasma norepinephrine concentration (PNE) at 1 month was higher in animals that subsequently developed AF (576 + 101 vs. 425 + 197 pg/mL, P = .03). There were no significant differences between the groups in 1-month LV end-diastolic pressure (LVEDP), pulmonary artery wedge pressure (PAWP), cardiac output, end-diastolic volume (EDV), LVEF, or plasma renin activity (PRA). At 4 months, cardiac output was lower (2.1 + .4 vs. 2.6 + .6 L/h, P = .02) and PNE was higher (1036 + 857 vs. 508 + 288 pg/mL, P = .03) in dogs with AF versus those in sinus rhythm. There were no significant differences between groups in 4-month LVEDP, PAWP, EDV, LVEF, or PRA.
CONCLUSION: Spontaneous AF in heart failure was preceded by a significant increase in PNE. In animals that developed AF, there was a further decline in cardiac output and increase in PNE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174237     DOI: 10.1016/j.cardfail.2006.08.005

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  7 in total

Review 1.  Atrial fibrillation in congestive heart failure.

Authors:  Steven A Lubitz; Emelia J Benjamin; Patrick T Ellinor
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

Review 2.  Atrial fibrillation and heart failure: cause or effect?

Authors:  Christina Luong; Marion E Barnes; Teresa S M Tsang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 3.  Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.

Authors:  Parikshit S Sharma; David J Callans
Journal:  J Atr Fibrillation       Date:  2013-08-31

4.  Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism.

Authors:  Ryan G Aleong; William H Sauer; Gordon Davis; Guinevere A Murphy; J David Port; Inder S Anand; Mona Fiuzat; Christopher M O'Connor; William T Abraham; Stephen B Liggett; Michael R Bristow
Journal:  JACC Heart Fail       Date:  2013-08       Impact factor: 12.035

Review 5.  Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship.

Authors:  J C Caldwell; M A Mamas
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 6.  Arrhythmias and vagus nerve stimulation.

Authors:  Youhua Zhang; Todor N Mazgalev
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

7.  Hyperuricemia Is Associated With the Risk of Atrial Fibrillation Independent of Sex: A Dose-Response Meta-Analysis.

Authors:  Jianhua Xiong; Wen Shao; Peng Yu; Jianyong Ma; Menglu Liu; Shan Huang; Xiao Liu; Kaibo Mei
Journal:  Front Cardiovasc Med       Date:  2022-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.